Live Research Database
Psoriasis
Hub: Indianapolis, IN
Connecting patients in Indianapolis with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Indiana
Available Psoriasis Opportunities
7 RecruitingNCT06857942(Verify)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT06663332(Verify)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RECRUITING
Psoriasis
NCT06100744(Verify)
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RECRUITING
Psoriasis
NCT02418442(Verify)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
Psoriasis
NCT06979453(Verify)
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RECRUITING
Psoriasis
NCT06425549(Verify)
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Indianapolis through safe, transparent, and patient-first clinical trials."
Research Hubs in Indianapolis
Explore other local breakthroughs
Psoriasis Hubs in IN
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT